doxorubicin HCl liposome

DRUG3 trials

Sponsors

National Cancer Institute (NCI), Case Comprehensive Cancer Center, Accelerated Community Oncology Research Network

Conditions

Bone CancerBrain TumorBreast CancerChildhood Liver CancerChildhood Soft Tissue SarcomaDrug/Agent Toxicity by Tissue/OrganEndometrial CancerFallopian Tube Cancer

Phase 1

Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

CompletedNCT00019630

National Cancer Institute (NCI)Bone Cancer, Brain Tumor, Childhood Liver Cancer +2

Start: 1999-07-31Updated: 2024-03-04

Phase 2

Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma

TerminatedNCT00366106

Accelerated Community Oncology Research NetworkMultiple Myeloma

Start: 2006-07-31End: 2011-03-31Updated: 2012-04-06

Phase 3

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

CompletedNCT00245050

Case Comprehensive Cancer CenterBreast Cancer, Drug/Agent Toxicity by Tissue/Organ, Endometrial Cancer +3

Start: 2004-04-30End: 2011-09-30Updated: 2011-12-30